Business Involvement metrics are not indicative of a fund’s investment objective, and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the NASDAQ Stock Market. This and other information can be found in the Funds' prospectuses or, if available, the summary prospectuses, which may be obtained by visiting the iShares Fund and BlackRock Fund prospectus pages. 1. If you need further information, please feel free to call the Options Industry Council Helpline. Dividend history information is presently unavailable for this company. That compares with a 16.6 percent gain for the Health Care Select Sector SPDR ( XLV ). All data is from MSCI ESG Fund Ratings as of Apr 07, 2021, based on holdings as of Feb 28, 2021. Although BlackRock shall obtain data from sources that BlackRock considers reliable, all data contained herein is provided “as is” and BlackRock makes no representation or warranty of any kind, either express or implied, with respect to such data, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Related Articles (IBB) The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data For more information regarding a fund's investment strategy, please see the fund's prospectus. iShares Nasdaq Biotechnology ETF (IBB) is the largest biotech ETF in the market. For more information regarding a fund's investment strategy, please see the fund's prospectus. 1. iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) Total assets: US$10.48 billion The iShares NASDAQ Biotechnology ETF was launched on February 5, 2001, and tracks over 280 holdings. As a result, it is possible there is additional involvement in these covered activities where MSCI does not have coverage. Fidelity may add or waive commissions on ETFs without prior notice. The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. Performance charts for iShares Nasdaq Biotechnology ETF (IBB - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. Free commission offer applies to online purchases of select iShares ETFs in a Fidelity account. Get iShares Nasdaq Biotechnology ETF (IBB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. IBB is somewhat top-heavy, but generally spreads exposure across large caps, mid caps, and small cap stocks. Fund Summary for IBB ISHARES NASDAQ BIOTECHNOLOGY ETF Find the latest quotes for iShares Nasdaq Biotechnology Index Fund (IBB) as well as ETF details, charts and news at Nasdaq.com. (for financial professionals only). The returns shown do not represent the returns you would receive if you traded shares at other times. Find out more about how we use your information in our Privacy Policy and Cookie Policy. None of these companies make any representation regarding the advisability of investing in the Funds. The IBB biotech index ETF provides excellent volatility and is likely to trade with the overall markets. These screens are described in more detail in the fund’s prospectus, other fund documents, and the relevant index methodology document. The metrics below have been provided for transparency and informational purposes only. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. This is one of the most concentrated ETFS with only 25 companies usually represented and assets under $1 billion. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. In other words, the larger t… Some funds may be based on or linked to MSCI indexes, and MSCI may be compensated based on the fund’s assets under management or other measures. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Discuss with your financial planner today. As such, the fund’s sustainable characteristics may differ from MSCI ESG Fund Ratings from time to time. Click here to find out more about our partners. Read the prospectus carefully before investing. The midpoint is the average of the bid/ask prices at 4:00 PM ET (when NAV is normally determined for most ETFs). Review the MSCI methodology behind the Business Involvement metrics, using links below. BlackRock expressly disclaims any and all implied warranties, including without limitation, warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose. The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Read the prospectus carefully before investing. IBB, Ishares Nasdaq Biotech - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Picking stocks in the biotech sector can be […] Find the latest iShares Nasdaq Biotechnology In (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. BlackRock business involvement exposures as shown above for Thermal Coal and Oil Sands are calculated and reported for companies that generate more than 5% of revenue from thermal coal or oil sands as defined by MSCI ESG Research. Business Involvement metrics are only displayed if at least 1% of the fund’s gross weight includes securities covered by MSCI ESG Research. Navigate evolving markets with iShares insights, MSCI Weighted Average Carbon Intensity (Tons CO2E/$M SALES). Low risk. IBB is actively-traded ETF that tracks the NASDAQ Biotechnology Index. PBE and FBT are other ETF options for biotech exposure; those considering this sector should take a close look at depth of exposure and weighing methodology, as these factors can have a major impact on the risk and return profiles achieved. MSCI has established an information barrier between equity index research and certain Information. This information should not be used to produce comprehensive lists of companies without involvement. IBB Factset Analytics Insight. Investing involves risk, including possible loss of principal. IBB, the largest biotech ETF, and XBI are up 19.2 percent and 32.9 percent, respectively, year to date. In depth view into IBB (iShares Nasdaq Biotechnology ETF) including performance, dividend history, holdings and portfolio stats. Neither MSCI ESG Research nor any Information Party makes any representations or express or implied warranties (which are expressly disclaimed), nor shall they incur liability for any errors or omissions in the Information, or for any damages related thereto. Neither FTSE nor NAREIT makes any warranty regarding the FTSE EPRA/NAREIT Developed Real Estate ex-U.S. Index or FTSE EPRA/NAREIT Global REIT Index; all rights vest in FTSE, NAREIT and EPRA.“FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. iShares Nasdaq Biotechnology ETF (IBB) 148.55 -0.84 ( … ©2021 BlackRock, Inc. BLACKROCK, BLACKROCK SOLUTIONS, BUILD ON BLACKROCK, ALADDIN, iSHARES, iBONDS, FACTORSELECT, iTHINKING, iSHARES CONNECT, FUND FRENZY, LIFEPATH, SO WHAT DO I DO WITH MY MONEY, INVESTING FOR A NEW WORLD, BUILT FOR THESE TIMES, the iShares Core Graphic, CoRI and the CoRI logo are trademarks of BlackRock, Inc., or its subsidiaries in the United States and elsewhere. WHY IBB? Certain sectors and markets perform exceptionally well based on current market conditions and iShares and BlackRock Funds can benefit from that performance. For funds with an investment objective that include the integration of ESG criteria, there may be corporate actions or other situations that may cause the fund or index to passively hold securities that may not comply with ESG criteria. The largest and most heavily-traded of the biotech ETFs, IBB, tracks the performance of the NASDAQ Biotechnology Index to which the new ProShares ETFs are linked. Business Involvement metrics are designed only to identify companies where MSCI has conducted research and identified as having involvement in the covered activity. BLACKROCK, BLACKROCK SOLUTIONS, BUILD ON BLACKROCK, ALADDIN, iSHARES, iBONDS, iTHINKING, iSHARES CONNECT, FUND FRENZY, LIFEPATH, SO WHAT DO I DO WITH MY MONEY, INVESTING FOR A NEW WORLD, BUILT FOR THESE TIMES, the iShares Core Graphic, CoRI and the CoRI logo are registered and unregistered trademarks of BlackRock, Inc., or its subsidiaries in the United States and elsewhere. ©2019 BlackRock, Inc. All rights reserved. The Information may not be used to create any derivative works, or in connection with, nor does it constitute, an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Prior to August 10, 2020, market price returns for BlackRock and iShares ETFs were calculated using the midpoint price and accounted for distributions from the fund. Analyzing iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) stock? Fired up all the way back in 2001, a share of this ETF carries an expense ratio of 0.47% a year; so every $1,000 invested gets hit with a $4.70 charge throughout the year, assuming the value of the fund doesn't change. Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the fund. For standardized performance, please see the Performance section above. IBB has an AUM of … Investing involves risk, including possible loss of principal. This information must be preceded or accompanied by a current prospectus. © 2021 BlackRock, Inc. All rights reserved. All other marks are the property of their respective owners. The largest of the biotech stock ETFs on Wall Street, IBB is a $9 billion fund that regularly trades more than 3 million shares daily. Distribution Yield and 12m Trailing Yield results may have period over period volatility due to factors including tax considerations such as treatment of passive foreign investment companies (PFICs), treatment of defaulted bonds or excise tax requirements; exceptional corporate actions; seasonality of dividends from underlying holdings; significant fluctuations in fund shares outstanding; or fund capital gain distributions. Targeted access to biotechnology and pharmaceutical stocks listed on the NASDAQ. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited. You can change your choices at any time by visiting Your Privacy Controls. Certain information contained herein (the “Information”) has been provided by MSCI ESG Research LLC, a RIA under the Investment Advisers Act of 1940, and may include data from its affiliates (including MSCI Inc. and its subsidiaries (“MSCI”)), or third party suppliers (each an “Information Provider”), and it may not be reproduced or redisseminated in whole or in part without prior written permission. This analysis can provide insight into the effective management and long-term financial prospects of a fund. Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing. Virtus LifeSci Biotech Clinical Trials ETF (BBC) Expense ratio: 0.79% The Virtus LifeSci Biotech … Invesco NASDAQ Biotech UCITS ETF SBIO: Invesco PowerShares: iShares Nasdaq … Please refer to the fund’s prospectus for more information. Beginning August 10, 2020, market price returns for BlackRock and iShares ETFs are calculated using the closing price and account for distributions from the fund. Index performance returns do not reflect any management fees, transaction costs or expenses. 149.39 +0.54 +0.36%. The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. View IBB's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at … iShares funds are available through online brokerage firms.All iShares ETFs trade commission free online through Fidelity. Read the prospectus carefully before investing. The screening applied by the fund's index provider may include revenue thresholds set by the index provider. To be included in MSCI ESG Fund Ratings, 65% of the fund’s gross weight must come from securities covered by MSCI ESG Research (certain cash positions and other asset types deemed not relevant for ESG analysis by MSCI are removed prior to calculating a fund’s gross weight; the absolute values of short positions are included but treated as uncovered), the fund’s holdings date must be less than one year old, and the fund must have at least ten securities. The biotech sector, as measured by the Nasdaq Biotechnology Index, has outperformed the broader market with a total return of 44.0% over the … Fund expenses, including management fees and other expenses were deducted. Investors who are looking to gain access to the biotech sector while assuming the least … Copies of this document may be obtained from your broker, from any exchange on which options are traded or by contacting The Options Clearing Corporation, One North Wacker Dr., Suite 500, Chicago, IL 60606 (1-888-678-4667). Investing involves risk, including possible loss of principal. If the Fund invests in any underlying fund, certain portfolio information, including sustainability characteristics and business-involvement metrics, provided for the Fund may include information (on a look-through basis) of such underlying fund, to the extent available. The Information has not been submitted to, nor received approval from, the US SEC or any other regulatory body. Sustainability Characteristics can help investors integrate non-financial, sustainability considerations into their investment process. iShares Nasdaq Biotechnology Index Fund (IBB) ETF Bio The investment objective of the iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Get them exclusively at Trader's Idea Flow. ICRMH0719U-885409, Review the MSCI methodology behind the Sustainability Characteristics and Business Involvement metrics: 1ESG Ratings; 2Index Carbon Footprint Metrics; 3Business Involvement Screening Research; 4ESG Screened Index Methodology; 5ESG Controversies. Indexes are unmanaged and one cannot invest directly in an index. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. The document contains information on options issued by The Options Clearing Corporation. None of the Information in and of itself can be used to determine which securities to buy or sell or when to buy or sell them. Business Involvement metrics are calculated by BlackRock using data from MSCI ESG Research which provides a profile of each company’s specific business involvement. A high-level overview of iShares Nasdaq Biotechnology ETF (IBB) stock. Any applicable brokerage commissions will reduce returns. iShares Nasdaq Biotechnology ETF ETF , IBB. Performance data is not currently available, Input a stock, or ETF or fund from any fund provider, and explore iShares ETFs based on correlation and holdings overlap data. Past performance does not guarantee future results. Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of "Characteristics and Risks of Standardized Options." You can select 'Manage settings' for more information and to manage your choices. This fund seeks to provide exposure to U.S. biotechnology and pharmaceutical stocks and tracks the Nasdaq Biotechnology Index. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above.Neither FTSE nor NAREIT makes any warranty regarding the FTSE NAREIT Equity REITS Index, FTSE NAREIT All Residential Capped Index or FTSE NAREIT All Mortgage Capped Index; all rights vest in NAREIT. Exposure to U.S. biotechnology and pharmaceutical companies, 2. They will be able to provide you with balanced options education and tools to assist you with your iShares options questions and trading. Here's a roundup of top developments in the biotech space over the last 24 hours. Learn how you can add them to your portfolio. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). The information displayed on this website may not include all of the screens that apply to the relevant index or the relevant fund. Index returns are for illustrative purposes only. The existence of an ESG rating is not indicative of how or whether ESG factors will be integrated into a fund. These metrics enable investors to evaluate funds based on their environmental, social, and governance (ESG) risks and opportunities. Share this fund with your financial planner to find out how it can fit in your portfolio. The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals. The Options Industry Council Helpline phone number is 1-888-Options (1-888-678-4667) and its website is www.888options.com. BlackRock leverages this data to provide a summed up view across holdings and translates it to a fund's market value exposure to the listed Business Involvement areas above. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). Performance chart data not available for display. For that fee, investors get exposure to 219 stocks, passively managed and weighted by the size of the company. Review the MSCI methodology behind Sustainability Characteristics, using links below. The IBB can be an uncertain, but an attractive prospect if seeking exposure to the biotech industry. For newly launched funds, sustainability characteristics are typically available 6 months after launch. For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain Fidelity Brokerage Services platforms and investment programs. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts. Business Involvement metrics can help investors gain a more comprehensive view of specific activities in which a fund may be exposed through its investments. IBB is known for providing of the US biotech companies that are exclusively listed on the NASDAQ Stock Market. Learn more. View Top Holdings and Key Holding Information for iShares Nasdaq Biotechnology In (IBB). All other marks are the property of their respective owners. Funds that concentrate investments in specific industries, sectors, markets or asset classes may underperform or be more volatile than other industries, sectors, markets or asset classes and than the general securities market. No statement in the document should be construed as a recommendation to buy or sell a security or to provide investment advice. This and other information can be found in the Funds' prospectuses or, if available, the summary prospectuses, which may be obtained by visiting the iShares ETF and BlackRock Fund prospectus pages. iShares Biotechnology Fund is the oldest and largest biotechnology fund around. The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The metrics are based on MSCI ESG Fund Ratings and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing. Looking for more stock ideas like this one? VanEck Vectors Biotech ETF (BBH) seeks to track the performance of the MVIS US Listed Biotech 25 Index. ETP's Prospectus Stated Objectives. ETF Introduction: IBB — iShares Nasdaq Biotechnology ETF Market News Video - Monday, April 6, 5:28 PM.